Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?. Issue 5 (May 2018)

Record Type:
Journal Article
Title:
Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?. Issue 5 (May 2018)
Main Title:
Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?
Authors:
Weekes, Colin D
Clark, Jeffrey W
Zhu, Andrew X
Abstract:
Is Part Of:
Lancet oncology. Volume 19:Issue 5(2018)
Journal:
Lancet oncology
Issue:
Volume 19:Issue 5(2018)
Issue Display:
Volume 19, Issue 5 (2018)
Year:
2018
Volume:
19
Issue:
5
Issue Sort Value:
2018-0019-0005-0000
Page Start:
591
Page End:
592
Publication Date:
2018-05
Subjects:
Oncology -- Periodicals
Neoplasms -- Periodicals
Cancérologie -- Périodiques
Oncologie
Oncology
Periodicals
Electronic journals
616.994005
Journal URLs:
http://www.sciencedirect.com/science/journal/14702045 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S1470-2045(18)30249-3 ↗
Languages:
English
ISSNs:
1470-2045
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5146.090000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
6399.xml